A standard immunoglobulin preparation produced from bovine colostra shows antibody reactivity and neutralization activity againstShiga-like toxins and EHEC-hemolysin ofEscherichia coli O157:H7

This publication has 25 references indexed in Scilit:

• Differences in verotoxin neutralizing activity of therapeutic immunoglobulins and sera from healthy controls
  Infection, 1993
• Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis
  The Journal of Pediatrics, 1992
• Characterization of Shiga-like Toxin Producing Escherichia coli (SLTEC) Isolated from Calves with and without Diarrhoea
  Zentralblatt für Bakteriologie, 1992
• Effect of subinhibitory concentrations of antibiotics on extracellular shiga-like toxin I
  Infection, 1992
• Long-term outcome and prognostic indicators in the hemolytic-uremic syndrome
  The Journal of Pediatrics, 1991
• Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome
  The Journal of Pediatrics, 1990
• Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: Clinical and epidemiologic observations
  The Journal of Pediatrics, 1990
• Toxin Genotypes and Plasmid Profiles as Determinants of Systemic Sequelae in Escherichia coli O157:H7 Infections
  The Journal of Infectious Diseases, 1989
• Protection by Milk Immunoglobulin Concentrate against Oral Challenge with EnterotoxigenicEscherichia coli
  New England Journal of Medicine, 1988
• A Severe Outbreak ofEscherichia coliO157:H7–Associated Hemorrhagic Colitis in a Nursing Home
  New England Journal of Medicine, 1987